Cubist Systematic Strategies’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-22,713
Closed -$65.2K 3213
2025
Q2
$65.2K Buy
22,713
+19,561
+621% +$51.7K ﹤0.01% 2759
2025
Q1
$8.51K Buy
3,152
+768
+32% +$2.88K ﹤0.01% 2766
2024
Q4
$5.63K Sell
2,384
-24,239
-91% -$64.5K ﹤0.01% 2874
2024
Q3
$63.1K Sell
26,623
-2,040
-7% -$4.49K ﹤0.01% 2745
2024
Q2
$55.9K Buy
+28,663
New +$97.4K ﹤0.01% 2695

Other funds holding GNLX

Cubist Systematic Strategies's GNLX Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Genelux (GNLX) in Q3 2025, closing a stake of 22,713 shares — an estimated $65.2K sold.

Cubist Systematic Strategies first reported a position in GNLX in Q2 2024 and held it in 5 quarters. The position peaked at $65.2K in Q2 2025. 57 funds tracked by Wall St. Rank hold GNLX as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Genelux position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 22,713 Genelux shares in Q3 2025, an estimated $65.2K.
  • Cubist Systematic Strategies first reported a position in Genelux in Q2 2024 and held it in 5 quarters.
  • Cubist Systematic Strategies's Genelux position peaked at $65.2K in Q2 2025.
  • 57 funds tracked by Wall St. Rank held Genelux as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.